December 23, 2008 — In the treatment of advanced ovarian cancer, neoadjuvant chemotherapy before surgical debulking may be the new standard of care — especially in countries where the scheduling of a ...
Landscape of functional DLL3 expression in gastroenteropancreatic neuroendocrine neoplasms (GEP NENs). This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...
OVATION 3 is IMUNON’s pivotal Phase 3 study of IMMN-001, an IL-12 gene-mediated immunotherapy, in women with advanced stage epithelial ovarian cancer. The study is supported with unprecedented overall ...
Development and validation of a proteo-metabolic panel for detection of asymptomatic ovarian cancer with minimal serum sample requirements: A multi-center prospective study.
Verywell Health on MSN
Peritoneal Cancer: A Rare Abdominal Cancer
Medically reviewed by Doru Paul, MD Key Takeaways Peritoneal cancer is a rare cancer that starts in the thin tissue lining the abdomen.Symptoms often appear late and can include abdominal pain, ...
The optimal timing of surgery in patients with resectable advanced ovarian cancer remains controversial. Should these patients receive the standard radical surgery followed by chemotherapy, or could ...
GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies against cancers and infectious diseases, today announced the expansion of its oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback